Home Healthcare Pharmaceuticals Naltrexone And Buprenorphine Market

Naltrexone And Buprenorphine Market Size, Share & Trends Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration (Oral Administration, Injectable Administration, Implantable Administration), By Application (Opioid use disorder (OUD), Alcohol use disorder (AUD)), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 04, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Naltrexone And Buprenorphine Market, By Product 2025-2034 (USD MILLION/ Units)
    1. Naltrexone
      1. Vivitrol
    2. Buprenorphine
      1. BELBUCA
      2. Sublocade 
      3. Suboxone
      4. Zubsolv
      5. Others
  2. Naltrexone And Buprenorphine Market, By Route of Administration 2025-2034 (USD MILLION/ Units)
    1. Oral Administration  
    2. Injectable Administration
    3. Implantable Administration
  3. Naltrexone And Buprenorphine Market, By Application 2025-2034 (USD MILLION/ Units)
    1. Opioid use disorder (OUD)
    2. Alcohol use disorder (AUD)
  4. Naltrexone And Buprenorphine Market, By Distribution Channel 2025-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  5. Regional Naltrexone And Buprenorphine Market
    1. North America
      1. North America Naltrexone And Buprenorphine Market By Product 2025-2034 (USD MILLION/ Units)
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
      2. North America Naltrexone And Buprenorphine Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral Administration  
        2. Injectable Administration
        3. Implantable Administration
      3. North America Naltrexone And Buprenorphine Market By Application 2025-2034 (USD MILLION/ Units)
        1. Opioid use disorder (OUD)
        2. Alcohol use disorder (AUD)
      4. North America Naltrexone And Buprenorphine Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.S.
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Canada
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    2. Europe
      1. Europe Naltrexone And Buprenorphine Market By Product 2025-2034 (USD MILLION/ Units)
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
      2. Europe Naltrexone And Buprenorphine Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral Administration  
        2. Injectable Administration
        3. Implantable Administration
      3. Europe Naltrexone And Buprenorphine Market By Application 2025-2034 (USD MILLION/ Units)
        1. Opioid use disorder (OUD)
        2. Alcohol use disorder (AUD)
      4. Europe Naltrexone And Buprenorphine Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.K.
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Germany
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. France
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Spain
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Italy
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Russia
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. Nordic
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      12. Benelux
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      13. Rest of Europe
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    3. APAC
      1. APAC Naltrexone And Buprenorphine Market By Product 2025-2034 (USD MILLION/ Units)
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
      2. APAC Naltrexone And Buprenorphine Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral Administration  
        2. Injectable Administration
        3. Implantable Administration
      3. APAC Naltrexone And Buprenorphine Market By Application 2025-2034 (USD MILLION/ Units)
        1. Opioid use disorder (OUD)
        2. Alcohol use disorder (AUD)
      4. APAC Naltrexone And Buprenorphine Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. China
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Korea
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Japan
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. India
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Australia
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Taiwan
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. South East Asia
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      12. Rest of Asia-Pacific
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Naltrexone And Buprenorphine Market By Product 2025-2034 (USD MILLION/ Units)
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
      2. Middle East and Africa Naltrexone And Buprenorphine Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral Administration  
        2. Injectable Administration
        3. Implantable Administration
      3. Middle East and Africa Naltrexone And Buprenorphine Market By Application 2025-2034 (USD MILLION/ Units)
        1. Opioid use disorder (OUD)
        2. Alcohol use disorder (AUD)
      4. Middle East and Africa Naltrexone And Buprenorphine Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. UAE
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Turkey
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Saudi Arabia
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. South Africa
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Egypt
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Nigeria
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. Rest of MEA
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    5. LATAM
      1. LATAM Naltrexone And Buprenorphine Market By Product 2025-2034 (USD MILLION/ Units)
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
      2. LATAM Naltrexone And Buprenorphine Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral Administration  
        2. Injectable Administration
        3. Implantable Administration
      3. LATAM Naltrexone And Buprenorphine Market By Application 2025-2034 (USD MILLION/ Units)
        1. Opioid use disorder (OUD)
        2. Alcohol use disorder (AUD)
      4. LATAM Naltrexone And Buprenorphine Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. Brazil
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Mexico
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Argentina
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Chile
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Colombia
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Rest of LATAM
        1. Naltrexone
          1. Vivitrol
        2. Buprenorphine
          1. BELBUCA
          2. Sublocade 
          3. Suboxone
          4. Zubsolv
          5. Others
        3. Oral Administration  
        4. Injectable Administration
        5. Implantable Administration
        6. Opioid use disorder (OUD)
        7. Alcohol use disorder (AUD)
        8. Hospital Pharmacies
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.